Skip to main content
. 2022 Nov 15;22:438. doi: 10.1186/s12886-022-02635-0

Table 1.

Characteristics at enrollment of subjects in the two groups followed for 1 year, mean ± SD or n (%)

Variables Combination group (n = 27) Control group (n = 26)
Age (year)
All 10.07 ± 1.44 9.80 ± 1.64
Age (8.0 to10.0 years) 9.77 ± 1.26 (n = 13) 9.65 ± 1.45 (n = 12)
Age (10.1 to 12.0 years) 10.34 ± 1.58 (n = 14) 9.98 ± 1.89 (n = 14)
Spherical equivalent refraction (SER, D)
All -2.81 ± 0.92 -2.81 ± 0.97
SER (-1.00 to -2.50D) -2.61 ± 1.04 (n = 14) -2.76 ± 1.24 (n = 13)
SER (-2.51 to -4.00 D) -3.10 ± 0.68 (n = 13) -2.84 ± 0.71 (n = 13)
Body mass index (kg/m2) 18.94 ± 4.12 17.48 ± 3.40
Age at myopia diagnosis (year) 8.80 ± 1.50 8.84 ± 1.66
Age at first wearing of glasses (year) 9.06 ± 1.62 8.83 ± 1.59

SER progression 1 year before

study enrollment (D)

-0.72 ± 0.48 -0.77 ± 0.38
Corneal curvature (D) 42.84 ± 1.38 42.88 ± 1.25
Corneal astigmatism (D) 1.07 ± 0.48 1.23 ± 0.44
Anterior chamber depth (mm) 3.59 ± 0.42 3.70 ± 0.25
Intraocular pressure (mmHg) 16.96 ± 3.13 16.47 ± 2.43
Pupil diameter (mm) 5.58 ± 1.48 5.72 ± 1.19
Accommodative amplitude (D) 16.11 ± 3.67 15.99 ± 4.03
Axial length (mm) 24.79 ± 0.72 24.64 ± 0.79
Male, n (%) 10 (37.04%) 15 (57.69%)
Heredity
- - (neither parent myopic) 2 (7.41%) 5 (20.00%)
+ - (one parent myopic) 11 (40.74%) 9 (36.00%)
+ + (both parents myopic) 14 (51.85%) 11 (44.00%)

Note: Combination group: combination of OK lens and 0.01% atropine eye drops; Control group: combination of OK lens and placebo